Given that approximately 560 million East Asians (8% of the world population) carry this mutant allele (Chen et al, 2014), our results gain a substantial translational relevance as they predict a low occurrence of BRCA2‐mutated breast and ovarian cancers in this population. The gene discussed is BRCA2; the disease is ovarian cancer.